Chief Executive Officer, Co-Founder
CurrentI lead a Maryland-based biotechnology firm translating early stage technologies into Molecular Medicines addressing unmet medical needs, particularly in oncology, CNS/neurodegenerative, and rare diseases. We leverage a Hub-and-Spoke Corporate structure allowing us to take a diversified approach that maximizes innovation and operational efficiency; while.